These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19. Liu Y; Liao W; Wan L; Xiang T; Zhang W Viral Immunol; 2021 Jun; 34(5):330-335. PubMed ID: 32297828 [TBL] [Abstract][Full Text] [Related]
6. Circulatory Cytokine Levels as a Predictor of Disease Severity in COVID-19: A Study from Western India. Bhandari S; Rankawat G; Mathur S; Kumar A; Sahlot R; Jain A J Assoc Physicians India; 2022 May; 70(5):11-12. PubMed ID: 35598128 [TBL] [Abstract][Full Text] [Related]
7. A deficient immune response to SARS-CoV-2 in the nasopharynx is associated with severe COVID-19 pneumonia. Pita-Martínez C; Pérez-García F; Virseda Berdices A; Martin-Vicente M; Castilla-García L; Hervás Fernández I; González Ventosa V; Muñoz-Gómez MJ; Cuadros-González J; Bermejo-Martin JF; Resino S; Martínez I Int J Infect Dis; 2023 Sep; 134():126-132. PubMed ID: 37290572 [TBL] [Abstract][Full Text] [Related]
8. Decreased circulating CD73 and adenosine deaminase are associated with disease severity in hospitalized patients with COVID-19. Rud J; Riker RR; Eldridge A; Lord C; deKay JT; May TL; Gagnon DJ; Sawyer D; Ryzhov S; Seder DB Int J Immunopathol Pharmacol; 2023; 37():3946320231185703. PubMed ID: 37364162 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic Performance of Self-Collected Saliva Versus Nasopharyngeal Swab for the Molecular Detection of SARS-CoV-2 in the Clinical Setting. Uddin MKM; Shirin T; Hossain ME; Alam AN; Ami JQ; Hasan R; Miah M; Shaly NJ; Ahmed S; Rahman SMM; Rahman M; Banu S Microbiol Spectr; 2021 Dec; 9(3):e0046821. PubMed ID: 34730436 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic Performance Assessment of Saliva RT-PCR and Nasopharyngeal Antigen for the Detection of SARS-CoV-2 in Peru. Calderón RI; Jhaveri TA; Tovar MA; Palomino JS; Barreda NN; Sanabria OM; Peinado J; Ramirez C; Llanos Zavalaga LF; Valderrama G; Franke MF; Mitnick CD; Lecca L; Velásquez GE Microbiol Spectr; 2022 Aug; 10(4):e0086122. PubMed ID: 35867471 [TBL] [Abstract][Full Text] [Related]
11. Inflammatory mediators profile in patients hospitalized with COVID-19: A comparative study. Tufa A; Gebremariam TH; Manyazewal T; Getinet T; Webb DL; Hellström PM; Genet S Front Immunol; 2022; 13():964179. PubMed ID: 35958594 [TBL] [Abstract][Full Text] [Related]
12. Differential diagnosis of tuberculous and malignant pleural effusions: comparison of the Th1/Th2 cytokine panel, tumor marker panel and chemistry panel. Zhang J; Chen Y; He G; Jiang X; Chen P; Ouyang J Scand J Clin Lab Invest; 2020 Jul; 80(4):265-270. PubMed ID: 32108543 [TBL] [Abstract][Full Text] [Related]
13. Routine laboratory testing to determine if a patient has COVID-19. Stegeman I; Ochodo EA; Guleid F; Holtman GA; Yang B; Davenport C; Deeks JJ; Dinnes J; Dittrich S; Emperador D; Hooft L; Spijker R; Takwoingi Y; Van den Bruel A; Wang J; Langendam M; Verbakel JY; Leeflang MM; Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013787. PubMed ID: 33211319 [TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of cytokine measurement in pleural effusion]. Naito T; Ohtsuka M; Ishikawa H; Satoh H; Hasegawa S Kekkaku; 1997 Oct; 72(10):565-72. PubMed ID: 9386355 [TBL] [Abstract][Full Text] [Related]
15. Pleural fluid adenosine deaminase/serum C-reactive protein ratio for the differentiation of tuberculous and parapneumonic effusions with neutrophilic predominance and high adenosine deaminase levels. Lee J; Yoo SS; Lee SY; Cha SI; Park JY; Kim CH Infection; 2017 Feb; 45(1):59-65. PubMed ID: 27488820 [TBL] [Abstract][Full Text] [Related]
16. Role of Innate and Adaptive Cytokines in the Survival of COVID-19 Patients. Monserrat J; Gómez-Lahoz A; Ortega MA; Sanz J; Muñoz B; Arévalo-Serrano J; Rodríguez JM; Gasalla JM; Gasulla Ó; Arranz A; Fortuny-Profitós J; Mazaira-Font FA; Teixidó Román M; Martínez-A C; Balomenos D; Asunsolo A; Álvarez-Mon M; On Behalf Of The Covid-Hupa Group Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142255 [TBL] [Abstract][Full Text] [Related]
17. Comparison of SARS-CoV-2 PCR-Based Detection Using Saliva or Nasopharyngeal Swab Specimens in Asymptomatic Populations. Fan G; Qin X; Streblow DN; Hoyos CM; Hansel DE Microbiol Spectr; 2021 Sep; 9(1):e0006221. PubMed ID: 34431689 [TBL] [Abstract][Full Text] [Related]
18. Cytokines in pleural liquid for diagnosis of tuberculous pleurisy. Yamada Y; Nakamura A; Hosoda M; Kato T; Asano T; Tonegawa K; Itoh M Respir Med; 2001 Jul; 95(7):577-81. PubMed ID: 11453314 [TBL] [Abstract][Full Text] [Related]
19. Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection. Bozorgmehr N; Mashhouri S; Perez Rosero E; Xu L; Shahbaz S; Sligl W; Osman M; Kutsogiannis DJ; MacIntyre E; O'Neil CR; Elahi S mBio; 2021 May; 12(3):. PubMed ID: 33947753 [TBL] [Abstract][Full Text] [Related]
20. The Utility of Pleural Fluid Lactate Dehydrogenase to Adenosine Deaminase Ratio in Pleural Tuberculosis. Beukes A; Shaw JA; Diacon AH; Irusen EM; Koegelenberg CFN Respiration; 2021; 100(1):59-63. PubMed ID: 33333531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]